Cannabinoid therapy may provide symptomatic relief to patients afflicted with Alzheimer's while also moderating the progression of the dis-ease.
Amyotrophic Lateral Sclerosis
Recent preclinical findings indicate that cannabinoids can delay ALS progression and may be efficacious in moderating the dis-ease's development and in alleviating certain ALS related symptoms such as pain, appetite loss, depression and drooling.
Survey data indicates that the use of cannabis is common among patients with chronic pain and a majority of patients who use it for this indication report it being effective.
It is reasonable to consider cannabinoids as a treatment option for the management of chronic neuropathic pain with evidence of efficacy in other types of chronic pain such as fibromyalgia and rheumatoid arthritis as well.